about
Educational interventions to improve prescribing competency: a systematic review.Validating a hospital medicines formulary survey in the Western Pacific Region--a global hospital pharmacy initiative based on the Basel Statements.The impact of clinical pharmacy services in China on the quality use of medicines: a systematic review in context of China's current healthcare reform.Clinical pharmacy services that influence prescribing in the Western Pacific Region based on the FIP Basel Statements.Factors Associated with Patient Preferences for Disease-Modifying Therapies in Multiple Sclerosis.A needs assessment of community pharmacists for pharmacist specialization in Canada.Revision of the International Pharmaceutical Federation's Basel Statements on the future of hospital pharmacy: From Basel to Bangkok.Minding the Gap: Factors Associated With Primary Care Coordination of Adults in 11 Countries.Preparing hospital pharmacists to prescribe: stakeholders' views of postgraduate courses.Risk factors for i.v. compounding errors when using an automated workflow management system.Strategies and policies to address the opioid epidemic: A case study of Ohio.Complementary medicine use by people living with HIV in Australia - a national survey.Part 1: Barriers to the advancement of the pharmacy professionPart 2: Roles and expertise needed to move the profession forward and improve health outcomes.Part 3: Perspectives of pharmacy technicians on practice change.Part 5: Future vision for the pharmacy profession.Hospital pharmacy workforce in Brazil.Factors affecting the implementation of clinical pharmacy services in China.The Revised Basel Statements on the Future of Hospital Pharmacy: What Do They Mean for Saudi Arabia?Applying Lean Techniques to Reduce Intravenous Waste Through Premixed Solutions and Increasing Production Frequency.Pharmacists' influences on prescribing: validating a clinical pharmacy services survey in the Western Pacific Region.Emergency Physicians' Perception of Barriers and Facilitators for Adopting an Opioid Prescribing Guideline in Ohio: A Qualitative Interview StudyWorld Hospital Pharmacy Research ConsortiumHospital pharmacy services in the Pacific Island countriesFormulary systems and pharmacy and therapeutics committees in the Western Pacific Region: Exploring two Basel StatementsInvestment Opportunities in Australia’s Healthcare Stock Markets After the Recent Global Financial CrisisPredicting ASX Health Care Stock Index Movements After the Recent Financial Crisis Using Patterned Neural NetworksCompetency-based pharmacy education in the Eastern Mediterranean Region—A scoping reviewThe impacts of medication shortages on patient outcomes: A scoping reviewCorrelation of the Pharmacy Curriculum Outcomes Assessment and Selected Pre-pharmacy and Pharmacy Performance VariablesCombatting Opioid Overdoses in Ohio: Emergency Department Physicians' Prescribing Patterns and Perceptions of NaloxoneMandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensingThe impact of using an intravenous workflow management system (IVWMS) on cost and patient safetyStatewide cross-sectional survey of emergency departments' adoption and implementation of the Ohio opioid prescribing guidelines and opioid prescribing practicesQualitative Analysis of Student Pharmacists' Reflections of Harvard's Race Implicit Association TestChallenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysisDefining and identifying concepts of medication reconciliation: An international pharmacy perspectiveEmergency department physicians' and pharmacists' perspectives on take-home naloxoneEffectiveness of interventions on the appropriate use of opioids for noncancer pain among hospital inpatients: A systematic reviewImpact of a pharmacy technician on clinical pharmacy services in an Australian hospital
P50
Q37136854-D1367292-A5BB-48B1-AB39-6FFD791C69F0Q37968394-22C10E9D-BEDB-4187-937A-B6EFB59EA0A6Q38140645-63B6EC19-AA37-4BAC-B54F-6C06FCFA9804Q38366992-BCD3D3A7-8809-485B-84DD-CF5AE3B348F7Q38664891-D01D6A9E-C733-4CFC-B097-83A6CD2E3B00Q38834787-091D0961-4A2A-482C-AC63-375EBE0F2CCBQ38836940-2B091053-6F89-4AE3-B18E-85374187CFC1Q38910437-8C229C70-8E0D-4ECC-A594-6A6A16661A33Q39465599-9AB8EE91-FCF2-4537-A3EF-8215994AD25CQ39710444-3997811C-B551-4DB1-BF14-CEEFD2836A01Q40339563-F5CCEFC0-D886-42F7-9069-090F8EFCC850Q41437177-BB3B6977-2518-468A-ADE0-EDB811F8180FQ42094553-AB7E5EE7-D38C-4AEA-AAD3-2187B95ACB20Q42289783-5760CBD3-907E-429C-8F42-7F425F492EAEQ46000590-E30DFDAF-46F5-4296-AB4F-12AC7D539382Q47157650-B3615B85-0C08-4CE5-BAB8-16EE3D715745Q47208488-F3397391-1E39-4364-A02D-3B50F9F3AD40Q47668300-7C080B0A-D05F-4AAE-AF2B-D2EE24142B4EQ47963526-AB4B8240-1285-4696-992A-4DEC5235FED5Q51314538-920BFBF0-7985-4C55-8B51-AD443D501DFAQ51811734-6E6D6589-E52E-427D-84AD-97780A14858CQ57813602-55D97135-DCE3-45D6-B801-B17D0A0CBBC1Q59221737-24DCD738-4405-498C-9178-46FC44CB3D45Q59221749-F3AC38B1-EA3A-4B30-A7D6-0AA5B114DA56Q59221778-3C30DCA3-2A96-4928-A244-75C4C141C369Q59221786-4D6851FB-C795-4CD3-A1DC-9543429FC557Q59221798-217A66E2-6172-4FEF-8AD4-7AAB9A7DAB35Q61426652-3DBA91F1-9B8B-42DC-9F84-52C107F77672Q64069117-F4E30C58-8FCE-4944-8ED4-9612490D9617Q64087648-649594E2-6A66-4050-886C-9B8FD8B34913Q87916998-FD6E2F97-D56D-41C0-971B-088DBF003A57Q88737522-0E803DD6-4D6D-41B2-902C-CE6356A2F1BFQ88740703-9068570F-4A82-446F-AA37-AECD640509A1Q89365679-6369DBDD-E237-4810-9BD1-1D90EACE70E0Q89479200-B8B0E672-9B88-4399-B98D-F316C799D48CQ90711253-F352E17B-B0F2-4CD7-BC25-283173A6D3EBQ90903373-34D77639-AD23-47E9-975C-941E9AFD0B3EQ91274747-D0DA88E8-EE01-48AE-B195-7AAA1757EA98Q92166872-EC8B027F-16C2-4849-AAD5-412992B41C8CQ92318805-61C746C4-AEE6-4B58-A6DF-804A87077779
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jonathan Penm
@ast
Jonathan Penm
@en
Jonathan Penm
@es
Jonathan Penm
@nl
Jonathan Penm
@sl
type
label
Jonathan Penm
@ast
Jonathan Penm
@en
Jonathan Penm
@es
Jonathan Penm
@nl
Jonathan Penm
@sl
prefLabel
Jonathan Penm
@ast
Jonathan Penm
@en
Jonathan Penm
@es
Jonathan Penm
@nl
Jonathan Penm
@sl
P106
P1153
55642014200
P21
P31
P496
0000-0001-9606-7135